HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £2,529 | £3,061 | £2,529 | £5,685 |
| - Cash | £154 | £284 | £313 | £378 |
| + Debt | £90 | £86 | £27 | £39 |
| Enterprise Value | £2,464 | £2,864 | £2,243 | £5,347 |
| Revenue | £630 | £838 | £426 | £356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Gross Profit | £281 | £152 | £115 | £98 |
| % Margin | 44.6% | 18.1% | 27% | 27.5% |
| EBITDA | £14 | £67 | -£401 | -£321 |
| % Margin | 2.2% | 8% | -94.1% | -90.2% |
| Net Income | £38 | £101 | -£361 | -£195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.25 |
| % Growth | -64% | 127.9% | -72% | – |
| Operating Cash Flow | £0 | £219 | -£269 | -£204 |
| Capital Expenditures | -£18 | -£33 | -£37 | -£17 |
| Free Cash Flow | -£17 | £187 | -£305 | -£221 |